In vitro and in vivo antidermatophytic activity of the dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva Hiern (Araliaceae)

BMC Complementary and Alternative Medicine

Jules-Roger Kuiate³  Paul Keilah Lunga²  Raymond Simplice Mouokeu¹  Donatien Gatsing³  Guy Sedar Singor Njateng³ 

[1] Institute of Fisheries and aquatic sciences, University of Douala-Cameroon, PO box 2701, Douala, Cameroon;Laboratory of Phytobiochemistry and Medicinal Plants Study, Faculty of Science, University of Yaoundé 1, P.O. Box 812, Yaoundé, Cameroon;Laboratory of Microbiology and Antimicrobial Substances, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon

关键词: Guinea pigs;    Primary irritation index;    Irritation test;    Extract-oil formulation;    Polyscias fulva;    Antidermatophytic activity;   

Others  :  1230050
DOI  :  10.1186/1472-6882-13-95

 received in 2012-06-15, accepted in 2013-04-29,  发布年份 2013

【 摘 要 】

Background

During the last decades, the number of people suffering from dermatophytoses has seriously increased, mainly due to the development of resistant strains of microorganisms to a range of formally efficient antibiotics. Polyscias fulva, a medium size tree which grows in the West Region of Cameroon is traditionally used for local application against dermatoses and orally against venereal infections. The dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva was evaluated for its in vitro and in vivo antifungal activities.

Methods

The plant extract was prepared by maceration of its stem bark powder in CH₂Cl₂-MeOH (1:1 v/v). The extract obtained was successively partitioned in hexane, ethyl acetate and n-butanol. Phytochemical screening was performed using standard methods. In vitro antidermatophytic activity was assayed by the well diffusion and broth microdilution methods. The degree of dermal irritation of the crude extract was determined in guinea pigs using the occluded dermal irritation test method. The in vivo antidermatophytic activity of the extract-oil formulation (1.25, 2.5 and 5% w/w concentrations) was evaluated using Trichophyton mentagrophytes-induced dermatophytosis in a guinea pigs model.

Results

Phytochemical screening indicated that, the crude extract, ethyl acetate, n-butanol and residue fractions contain in general saponins, tannins, alkaloids, anthraquinones and phenols while the hexane fraction contains only alkaloids. The ethyl-acetate, n-butanol and residue fractions displayed higher antifungal activities (MIC = 0.125-0.5 mg.mL^-1) against eight dermatophytes as compared to the crude extract (MIC = 0.5-1 mg.mL^-1). This latter appeared to have slight perceptible erythema effects on guinea pigs as the primary irritation index (PII) was calculated to be 0.54. In vivo, the antidermatophytic activities of the extract-oil formulations were dose-dependent. Griseofulvin-oil 5% at 0.01 g/kg and formulated extract-oil (5%) at 0.1 g/kg eradicated the microbial infection after thirteen and fourteen days of daily treatment respectively.

Conclusions

The results of preclinical in vitro and in vivo evaluations indicate that the extract-oil formulation at 5% may constitute an alternative means to alleviate fungal infections caused by dermatophytes.

【 授权许可】

   
2013 Njateng et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Weitzman I, Summerbell RC: The Dermatophytes. Clin Microbiol Rev 1995, 8:240-259.
• [2]Ananth BD, Maheswara U, Reddy C: Antimicrobial activity of Methanol Extract of Oxystelma esculentum. J Pharm Sci Technol 2010, 2:119-123.
• [3]Lorougnon F, Heron P, Therizol M, Kanga J, Djeha D, Yoboue P, Boussou D: Efficacité clinique de la naftifine dans le traitement des dermatomycoses. Médecine d’Afrique noire 1991, 38:707-714.
• [4]Sorberon JR, Sgariglia MA, Sampietro DA, Quiroga EN, Vattuone MA: Antibacterial activity of plant extracts from North-western Argentina. J Appl Microbiol 2007, 102:1450-1461.
• [5]Ghannoum AM, Rice BL: Antifungal agent: mode of action, mechanisms of resistance and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999, 12:501-517.
• [6]Akiniyemi KO, Oladapo O, Okwara CE, Ibe C, Fasure KA: Screening of crude extracts of six medicinal plants used in south-west Nigerian unorthodox medicine for anti-methicillin resistant- Staphylococcus aureus activity. Complement Alt Med 2005, 5:5-8. BioMed Central Full Text
• [7]Santos PRV, Oliveira ACX, Tomassini TCB: Controle microbiógico de produtos fitoterápicos. Rev Farm Bioquím 1995, 31:35-38.
• [8]Nascimento GGF, Locatelli J, Freitas PC, Silva GL: Antibacterial activity of plants extracts and phytochemical on antibiotic-resistant bacteria. Braz J Microbiol 2000, 31:247-256.
• [9]Ndaya TJ, Chifundera K, Kaminsky R, Wright AD, Konig GM: Screening of African medicinal plants for antimicrobial and enzyme inhibitory activity. J Ethnopharmacol 2002, 80:25-27.
• [10]Focho DA, Ndam WT, Fonge BA: Medicinal plants of Aguambu – Bamumbu in the Lebialem highlands, southwest province of Cameroon. Afr J. Pharm Pharmaco 2009, 3:001-013.
• [11]Bedir E, Toyang NJ, Khan IA, Walker LA, Clark AM: A new dammarance-type triterpene glycoside from Polyscias fulva. J Nat Prod 2001, 64:95-99.
• [12]Mitaine-Offer AC, Tapondjou LA, Lontsi D, Sondengam BL, Choudhary MI, Atta-Ur-Rahman L-DMA: Constituents isolated from Polyscias fulva. Biochem syst ecol J 2004, 32:607-610.
• [13]Aghel N, Moghimipour E, Ameri A: Characterization of an anti-dermatophytic cream from Zataria multiflora Boiss. Iran J Pharm Sci 2007, 3:77-84.
• [14]Moghimipour E, Ameri A, Saudatzadeh A, Salimi A, Siahpoosh A: Formulation of an antidermatophytic cream from hydro-alcoholic extract of Eucalyptus camaldulensis leaves. Jundishapur J Nat Pharm Prod 2009, 4:32-40.
• [15]Thirumalai T, David E, Viviyan SV, Therasa EEK: Restorative effect of Eclipta alba in CCl4 induced hepatotoxicity in male albino rats. Asian Pac J Trop Med: 2011, 304-307.
• [16]Salie F, Eagles PFK, Leng HMJ: Preliminary antimicrobial screening of four South African asteraceae species. J Ethnopharmacol 1996, 52:27-33.
• [17]OECD guidelines for testing of chemicals: Repeated dose dermal toxicity: 21/28-day study. OECD guideline for testing chemicals 1981, 410:1-8.
• [18]OECD guidelines for testing of chemicals: Acute dermal toxicity. OECD guideline for testing chemicals 1987, 402:1-7.
• [19]Harbone SB: Baxter H (1996) Phytochemical dictionary . London: A handbook of bioactive compounds from plants. Taylor Francis; 1996.
• [20]Iwata K, Yamashita T, Vehara H: In vitro and in vivo activities of piritetrate (M.372), a new antidermatophyticthiocarbamate. Antimicrob agents ch 1989, 33:2118-2125.
• [21]Rios JL, Recios MC, Willar A: Screening method for natural product with antimicrobial activity: a review of literature. J Ethnopharmacol 1988, 23:127-149.
• [22]Gulluce M, Sokmen M, Dafera D, Aga RG, Ozkan F: In vitro antibacterial, antifungal and antioxidant activities of herbal parts and callus cultures of Satureja hortensis L. J Agric Food Chem 2003, 51:3958-3965.
• [23]Auletta CS, CRC: From Acute, subchronic toxicology. In Handbook of toxicology. London: Derelanko and Hollinger; 1995:51-162.
• [24]Draize JH: (1959) The appraisal of chemicals in foods, drugs and cosmetics . The association of food and drugs officials of the United States: Austin Texas USA; 1959.
• [25]Polak A: Experimental models in antifungal chemotherapy. Mycoses 1998, 41:1-30.
• [26]Wahabe S, Tandon RN, Jacob Z, Chandra B, Srivastava OP: Comparative in vitro and in vivo effect of lactones and arnabine on Trichophyton mentagrophytes and Candida albicans. Indian J Med Res 1982, 76:77-82.
• [27]Cray SM: Douglas: Mycology for clinical laboratories . Virginia: Reston publishing company inc; 1979.
• [28]Hainer BL: Dermatophyte Infections. Am Fam Physician 2003, 67:101-109.
• [29]Cowan MM: Plant products as antimicrobial agents. Clin Microbiol Rev 1999, 12:564-582.
• [30]Kuiate JR, Mouokeu S, Wabo HK, Tane P: Antidermatophytic triterpenoids from Syzygium jambos (L.) Alston (Myrtaceae). Phytother Res 2007, 21:149-152.
• [31]Njateng GSS, Kuiate JR, Gatsing D, Tamokou JD, Mouokeu S, Kuete V: Antidermatophytic activity and dermal toxicity of essential oil from the leaves of Ageratum houstonianum (Asteraceae). J Biol Sci 2010, 10:448-454.
• [32]Kuiate JR, Bessière JM, AmvamZollo PH, Kuate SP: Chemical composition and antidermatophytic properties of volatile fractions of hexanic extract from leaves of Cupressus lusitanica Mill from Cameroon. J Ephnopharmacol 2006, 103:160-165.
• [33]Kishore N, Chansouria JPN, Dubey NK: Antidermatophytic action of the essential oil of Chenopodium ambrosioides and an ointment prepared from it. Phytother res 1996, 10:453-455.
• [34]Zielinska M, Kostrzewa A, Ignatowicz E, Budzianowski J: The flavonoids, quercetin and isorhamnetin 3-O-acylglucosides diminish neutrophil oxidative metabolism and lipid peroxidtion. Acta Biochim Pol 2001, 48:183-189.
• [35]Kefale T, Tsige GM, Kaleab A, Ephrem E: Toxicity studies on dermal application of plant extract of Dodonaea viscose used in Ethiopian traditional medicine. Phytotherapy research J 2010, 24:60-69.
• [36]Derelanko MJ, Hollinger MA: (1995) Handbook of toxicology . Boca Raton, Florida: CRC press; 1995.
• [37]Gerberick GF, Vassalo DJ, Bailey RE, Chaney JG, Morrall SW, Lepoittevin JP: Development of a peptide reactivity assay for screening contact allergens. Toxicol Sci 2004, 81:332-343.